Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston
Biotech
How Boston biotechs cope with shallower pool of seed funding
With the average seed round dropping 40% in the first half of the year, CEOs and investors told Fierce where they think the industry is heading.
Will Maddox
Oct 16, 2026 7:00am
‘It’s just survival’: Why a third of Boston lab space sits empty
Oct 8, 2026 8:00am
AZ hopes for ‘amazing things’ from Kendall Square R&D center
Oct 6, 2026 5:30am
Fierce Pharma
Lundbeck relocating US headquarters to Boston in innovation move
Sep 25, 2026 10:41am
Singapore launches biotech-focused Boston hub with glitzy event
Sep 11, 2026 8:30am
Mass. governor acknowledges biotech capital 'harder to come by'
Sep 10, 2026 10:15am